FDA Approves Expanded Use of Luzu (luliconazole) Cream in Pediatric Patients with Athlete ’s Foot, Jock Itch and Ringworm

RALEIGH, N.C., FEBRUARY 22, 2018 – Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC (NYSE: VRX and TSX: VRX) (“Valeant”), today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news